The trajectory of companies tied to Viagra's legacy presents a challenging investment scenario . While the initial surge generated substantial gains, generic competition have significantly diminished sales https://bookmarketmaven.com/story22501227/copyright-s-flagship-product-and-big-pharma-a-uncertain-venture